You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 3, September 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acid Secretion Following Portacaval Shunting

Role of Vagus, Gastrin, Intestinal Phase, and Histamine

Philip H. Newman, MD; David D. Reeder, MD; Warren D. Davidson, MD; Edward Schneider; James H. Miller; James C. Thompson, MD

AMA Arch Surg. 1969;99(3):369-375.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Although certain facts have been demonstrated experimentally about gastric hypersecretion in dogs following portacaval transposition, the exact cause remains unclear.1,2 Hypersecretion has been shown to occur independently of hepatic parenchymal damage3 is not suppressed by elimination of the cephalic and antral phases of gastric secretion.4,5 Decreased hepatic catabolism or inactivation of a gastric secretagogue elaborated in the small intestine has been suggested by some investigators,5-8 and histamine has been suggested to be this secretagogue.9 Day and associates10 have shown increased levels of circulating and gastric mucosal histamine in rats with portacaval shunts. Recently, Fischer and Snyder11,12 have shown increased enzymatic activity of histidine decarboxylase in the gastric mucosa of rats with portacaval shunts and have been able to inhibit the gastric hypersecretion following portacaval shunt with brocresine (NSD-1055), a histidine decarboxylase inhibitor. The changes in gastric secretion brought about by portacaval shunting have . . . [Full Text PDF of this Article]


Author Affiliations

Torrance, Calif

From the departments of surgery and medicine, Harbor General Hospital, Torrance, and the School of Medicine, University of California at Los Angeles.


Footnotes

Submitted for publication March 10, 1969.

Read before the annual meeting of the Southern California Chapter of the American College of Surgeons, Jan 19, 1969.

Reprint requests to 1000 W Carson St, Torrance, Calif 90509 (Dr. Thompson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.